The rationale for targeting nectin-4 in pancreatic cancer

Key Points

• The aim is to establish nectin-4 as a viable therapeutic target in pancreatic ductal adenocarcinoma due to its role in tumor growth and immune response.
• Assessment of nectin-4 expression in pancreatic cancer cells.
• Review of clinical efficacy of nectin-4-targeted therapies in other tumors.
• Analysis of nectin-4's involvement in tumor aggressiveness and immune evasion.
• Nectin-4 shows high and selective expression on pancreatic cancer cells.
• Targeting nectin-4 could enhance therapeutic options for pancreatic ductal adenocarcinoma.
• Therapies targeting nectin-4 demonstrate promise in reducing tumor growth and improving immune response.